Fibrosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database
Condition:   Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion Interventions:   Drug: Larotrectinib (Vitrakvi, BAY2757556);   Drug: Standard of Care Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2022 Category: Research Source Type: clinical trials